3
ICAP

Bronx

Bronx Prevention Center

ICAP’s two research centers in New York, the Bronx Prevention Center and the Harlem Prevention Center, are hubs of research in New York City that have been historically underserved and disproportionately impacted by the HIV epidemic and, more recently, the COVID-19 epidemic. ICAP works with local community-based organizations, religious leaders, and advocates to promote community awareness of and engagement with the research studies.

Led by Wafaa El-Sadr, MD, MPH, MPA and Jessica Justman, MD, this work is supported through the ICAP at Columbia University Clinical Trials Unit (CTU). The ICAP CTU aims to support the design and implementation of research to address gaps in the global HIV response, including through clinical research sites in the Harlem, Bronx, and Eswatini.

The Community Advisory Board (CAB) for the ICAP Clinical Trials Unit (CTU) provides guidance and feedback on proposed studies, outreach strategies, feedback on study materials, and information regarding community perceptions of the potential or current research studies.

Current studies include investigations of antibody-mediated prevention using broadly neutralizing antibodies (bnAbs) to prevent HIV or COVID-19, an injectable long-acting pre-exposure prophylaxis (PrEP) option, mobile technologies to improve PrEP adherence, integrated care for people who inject opiates, HIV vaccine studies, and studies of COVID-19 immunity, vaccine efficacy, and treatment among others.

Through Columbia University, ICAP also supports additional COVID-19 surveys and various student fellowship programs, engaging students to participate in the design, implementation, and evaluation of ICAP-supported programs while working side-by-side with its experts.

Projects

Current Studies

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

Completed Studies

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

ICAP in Bronx

Program Start

2004

Key Technical Areas
  • Clinical Research and Trials
  • COVID-19 Research
  • PreP Research
Current Funders
  • National Institute of Health
    • National Institute of Allergy and Infectious Diseases (NIH/NIAID)
      Department of Health and Human Services (DHHS)
    • Family Health International (FHI)
    • Fred Hutchinson Cancer Research Center
  • AstraZeneca
  • Merck

 

 

Site Leader

Ellen Morrison, MD, MPH

Dr. Ellen Morrison is the Site Leader of the Columbia University Mailman School of Public Health ICAP Bronx Prevention Center CRS. She is a practicing board certified Infectious Disease physician who has been on the fulltime faculty at the Columbia University Irving Medical Center for more than 25 years.  Dr. Morrison has focused on clinical education, HIV testing and care, quality improvement, maternal infections, treatment of sexually transmitted infections, and the ethical review and conduct of clinical research.  She joined ICAP in 2018, where she serves as a Senior Technical Advisor for ICAP’s global health initiatives and is an investigator and site lead at the Bronx Prevention Center.  Dr. Morrison continues work on HIV prevention, including investigation of the provision of integrated services on a mobile van to engage out of care injection opiate users, and work on COVID-19 vaccines, testing of monoclonal antibodies and other COVID-19 treatment modalities.

 

Jobs in the United States

For international ICAP job listings see careers at ICAPACITY